Skin cancer Clinical Trials in Shreveport, LA
As of June 2026, 1 paid clinical trial is recruiting for Skin cancer in Shreveport, Louisiana. Skin cancer research focuses on immune checkpoint inhibitors, BRAF/MEK targeted therapy, adoptive cell therapy, and novel combinations for melanoma and non-melanoma skin cancers. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1 clinical trial for Skin cancer
·Clear filters·↓ Download CSVAbout research studies in Shreveport
Shreveport has approximately 171 recruiting research studies across a wide range of therapeutic areas. Louisiana hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Shreveport
Researchers run research studies in Shreveport, LA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| LSU Health Sciences Center at Shreveport | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 19 |
| LSU Health Shreveport | Focal Epilepsy, Adjustment Disorder, Apathy | 7 |
| Louisiana State University | Breast Cancer, COVID-19, Immunocompromised | 5 |
| Spine Institute of Louisiana | Adult Spinal Deformity, Degenerative Disc Disease, Degenerative Disc Disease (DDD) | 5 |
| CHRISTUS Highland Medical Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 4 |
| LSU Health Sciences Center | Breast Cancer, Chronic Kidney Diseases, HER2-positive Breast Cancer | 4 |
| Louisiana Research Center, LLC | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 4 |
| Grace Research, LLC-Shreveport-64616 | Heart Failure, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3 |
| Louisiana Research Center | Obesity or Overweight, Crohn's Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease | 3 |
| Louisiana State University Health Sciences Center | Incontinence, Urinary, Large B-cell Lymphoma, Non-Hodgkin Lymphoma | 3 |
| Louisiana State University Health Shreveport | Aneurysm, Brain, Interstitial Lung Disease (ILD), Proteinuric Kidney Disease | 3 |
| Ochsner LSU Health - Cancer Treatment Center | HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma, Anatomic Stage II Breast Cancer AJCC v8 | 3 |
| Trials365, LLC | Cervical Cancer, Endometrial Adenocarcinoma, Endometrial Cancer | 3 |
| Willis Knighton Cancer Center | Cervical Cancer, Colorectal Cancer, Oral Mucositis | 3 |
| Willis-Knighton Medical Center | Brain Tumor, Brain Tumor - Metastatic, Brain Tumor, Adult Meningioma | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive, Systemic Lupus Erythematosus | 2 |
| Kailera Clinical Site | Obesity, Obesity With Diabetes, Overweight With Diabetes | 2 |
| LSU Health Science Center Shreveport | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, PBC | 2 |
| Louisiana Research Center - GastroIntestinal Associates | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Louisiana Spine Institute | Adult Spinal Deformity, Kyphosis, Scoliosis | 2 |
| Louisiana State University Health Sciences Shreveport | COVID-19, Relapsed or Refractory Multiple Myeloma (RRMM) | 2 |
| Northwest Louisiana Nephrology | Focal Segmental Glomerulosclerosis, Kidney Disease | 2 |
| Ochsner LSU Health Saint Mary's Medical Center | Anatomic Stage IV Breast Cancer AJCC v8, Chronic Lymphocytic Leukemia, Elevated CA15-3 or CEA or CA27-29 | 2 |
| Trials365 LLC | Endometrial Cancer, Ovarian Cancer | 2 |
Active & Upcoming Studies in Shreveport (2026)
Recruiting trials in Shreveport grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (61 active studies)
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy · Phase 3 · Boehringer Ingelheim
- A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) · Phase 3 · Merck Sharp & Dohme LLC
Neurology & pain (12 active studies)
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight · Phase 3 · Eli Lilly and Company
- Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease · VIVEX Biologics, Inc.
Cardiovascular (12 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Diabetes & metabolic (11 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight · Phase 3 · Eli Lilly and Company
Mental health & behavior (4 active studies)
- Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder · Phase 2 · AbbVie
- Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. · Phase 3 · Louisiana State University Health Sciences Center Shreveport
Vaccines (2 active studies)
- EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease · Phase 3 · Pfizer
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study · Phase 3 · Ansun Biopharma, Inc.
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Shreveport
- Breast Cancer (5 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Endometrial Cancer (5 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Heart Failure (5 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Obesity (4 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Adult Spinal Deformity (3 active studies). Recruiting Adult Spinal Deformity studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Shreveport
- AstraZeneca
- Boehringer Ingelheim
- Merck Sharp & Dohme LLC
- NRG Oncology
- SWOG Cancer Research Network
Local regulations and guidelines
Clinical trials in Louisiana are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Louisiana research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Shreveport. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Shreveport
Hipa.ai aggregates every recruiting study in Shreveport from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Shreveport?
There are approximately 171 recruiting clinical trials in Shreveport, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Shreveport pay participants?
Most recruiting trials in Shreveport compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Shreveport?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Shreveport?
The most common conditions under active study in Shreveport include Breast Cancer (5), Endometrial Cancer (5), Heart Failure (5), Anatomic Stage II Breast Cancer AJCC v8 (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Shreveport?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Shreveport on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Shreveport?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Shreveport?
Recruiting research sites in Shreveport include LSU Health Sciences Center at Shreveport, LSU Health Shreveport, Louisiana State University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Shreveport right now?
The largest active categories in Shreveport are Cancer & tumors (61), Neurology & pain (12), Cardiovascular (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.